web maker

Chemotherapy, the term that identified the first systemic therapy for cancer was well chosen by founder Ezra Greenspan in 1968 to name this not-for-profit organization as The Chemotherapy Foundation. With the goal and purpose of incubating more curative therapies, the Foundation continues to serve as a launching pad for emerging developments in cancer medicine.

The Chemotherapy Foundation
Supporting Innovative Research for Continuing Progress 
in the Control and Cure of Cancer since 1968

Building the Bridge between the Laboratory Bench and Oncology Practice

(See Research Achievements of The Chemotherapy Foundation)

Your Contribution is an Investment in Continuing Progress

Half a century ago, when oncology was a newly recognized specialty of medicine, Ezra Greenspan opened a window to the future. He broke new ground in treating cancer patients with combinations of active agents, leading the way to targeted therapies, biologics, personalized medicine and the potent promises of gene therapy.

The Foundation Research Grant Program is providing startup seed money for the innovative investigators spearheading advances in cancer theraputics.


Benefit Events

Working Together to Overcome Ovarian Cancer, a Benefit Event partnering Medical Science and Show Business won plaudits from an audience of professionals and the public. We are pleased to hear from so many who gained greater understanding of the unprecedented progress ahead supported by cancer research.

Watch for announcements of future Foundation activities.

Many thanks to the Sponsors of the Chemotherapy Foundation Cancer Research Grant Program of 2018

Ezra Greenspan, MD

1919 - 2004
Founder of The Chemotherapy Foundation, Clinical Professor of Medicine, Mount Sinai School of Medicine

Dr. Greenspan was a pioneering oncologist who founded The Chemotherapy Foundation in 1968 and its professional education arm, The chemotherapy Foundation Symposium in 1972, to bring the new developments in cancer therapeutics to practicing oncologists in the years ahead. His goal was the control and eventual cure of cancer. His early work is widely recognized as a forerunner to current progress in combating many types of cancer.

Franco M. Muggia, MD

Chairman and Medical Director of The Chemotheraphy Foundation. Professor, Department of Medicine at The NYU Langone Medical Center

Dr. Muggia is a widely recognized expert and thought leader in clinical oncology. In collaboration with the Associate Medical Directors and the Scientific Advisory Council he is responsible for selection of the research projects and investigators funded by The Chemotherapy Foundation. He has published widely and lectured extensively in his specialty of gynecological cancers. During the years he headed the Cancer Therapy Evaluation Program at the National Cancer Institute he collaborated with Bonadonna, Fisher, Wolmark and other early leaders. With Ezra Greenspan he introduced the first Chemoprevention drug Tamoxifen. As leader of the Gynecologic Oncology Group he chaired the Medical Oncology Committee of the Gynecologic Oncology Group.

Edward P.  Ambinder, MD

Director of Medical Symposia
Clinical Professor of Medicine Emeritus, Hematology and Medical Oncology, Tisch Cancer Institute at the Icahn School of Medicine, Mount Sinai

Dr. Ambinder, a recognized leader in oncology education, practice management and informatics, is responsible for new educational and informatic initiatives of the Foundation. Dr. Ambinder serves on the Grant Review Committee of the Foundation.

The Chemotherapy Foundation is a 501(c)(3) not-for-profit charitable, educational,

scientific organization and your gift is tax deductible to the extent allowable by law.